Wired writes that the US National Academies of Science is examining what influences the microbiome of an indoor space.
A member of the committee issuing a blunt report on the inadequacy of biomarker-based testing speaks about what the next Secretary of HHS needs to do.
The National Academies of Sciences, Engineering, and Medicine says more study on the effect of gene drives is needed before they can be deployed.
The US National Academy of Sciences has announced 84 new members and 21 foreign associates.
US regulators are to discuss how to oversee crops modified using new gene-editing techniques.
Within certain limits, a National Academy panel says mitochondrial replacement techniques may be ethical.
Feng Zhang has shown how to systematically find and improve CRISPR systems, but scientists haven't settled on how to evaluate them for clinical use.
The organizing committee for the International Summit on Human Gene Editing advised against germline genome editing for clinical purposes.
Speakers considered the technical details of using genome editing in humans as well as the mechanisms for controlling it and its societal implications.
A National Academy committee recommends the development of a Research Policy Board to deal with the regulatory burden facing US researchers.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.